Skip to main content
Top
Published in: International Journal of Colorectal Disease 9/2011

01-09-2011 | Original Article

Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer

Authors: Jen-Kou Lin, Chun-Chi Lin, Shung-Haur Yang, Huann-Sheng Wang, Jeng-Kai Jiang, Yuan-Tzu Lan, Tzu-Chen Lin, Anna Fen-Yau Li, Wei-Shone Chen, Shih-Ching Chang

Published in: International Journal of Colorectal Disease | Issue 9/2011

Login to get access

Abstract

Purpose

Carcinoembryonic antigen (CEA) measurements performed preoperatively and during the early postoperative period were examined prospectively to assess their prognostic value for colorectal cancer (CRC) patients receiving curative surgery.

Methods

Between 2000 and 2004, 1,361 patients with CRC who underwent curative surgery at the Taipei Veterans General Hospital were enrolled prospectively. CEA was measured prior to surgery and during the third or fourth postoperative week. The endpoint was length of postoperative disease-free survival, and prognostic importance was determined using the log-rank test and Cox regression hazard model.

Results

Six hundred (44.1%) CRC patients had high CEA concentrations preoperatively, and 188 (13.8%) patients retained high values postoperatively. Within the median follow-up period of 61 (6–108) months, CRC recurred in 313 patients. By univariate analysis TNM staging, tumor differentiation, lymphovascular invasion, preoperative CEA concentration, and postoperative CEA concentration affected the outcome. By multivariate analysis, the prognostic importance of postoperative CEA was retained (95% CI, 1.73–3.01; HR = 2.28) but that of preoperative CEA was lost (95% CI, 0.82–1.33; HR = 1.05). CRC recurred earlier in patients with high postoperative CEA concentrations; metastasis to the liver was common (72.3%) among patients in this group.

Conclusions

Early postoperative CEA concentration is an independent prognostic factor for CRC. Patients with high postoperative CEA values should receive aggressive follow-up examinations for early relapse of CRC, with special attention paid to recurrence at the liver.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cancer registry annual report, Taiwan, R.O.C. The Department of Health, the Executive Yuan, R.O.C. December 2007 Cancer registry annual report, Taiwan, R.O.C. The Department of Health, the Executive Yuan, R.O.C. December 2007
2.
go back to reference Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124:979–994PubMed Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124:979–994PubMed
3.
go back to reference Desch CE, Benson AB III, Somerfield MR et al (2005) Colorectal cancer surveillance: 2005 update of an American Society of clinical oncology practice guideline. J Clin Oncol 23:8512–8519PubMedCrossRef Desch CE, Benson AB III, Somerfield MR et al (2005) Colorectal cancer surveillance: 2005 update of an American Society of clinical oncology practice guideline. J Clin Oncol 23:8512–8519PubMedCrossRef
4.
go back to reference Compton C, Fenoglio-Preiser CM, Pettigrew N et al (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 88:1739–1757PubMedCrossRef Compton C, Fenoglio-Preiser CM, Pettigrew N et al (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 88:1739–1757PubMedCrossRef
5.
go back to reference Bast RC Jr, Ravdin P, Hayes DF, American Society of Clinical Oncology Tumor Markers Expert Panel et al (2001) 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865–1878PubMed Bast RC Jr, Ravdin P, Hayes DF, American Society of Clinical Oncology Tumor Markers Expert Panel et al (2001) 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865–1878PubMed
6.
go back to reference Duffy MJ, van Dalen A, Haglund C et al (2003) Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 39:718–727PubMedCrossRef Duffy MJ, van Dalen A, Haglund C et al (2003) Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 39:718–727PubMedCrossRef
7.
go back to reference Locker GY, Hamilton S, Harris J, ASCO et al (2006) 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24:5313–5527PubMedCrossRef Locker GY, Hamilton S, Harris J, ASCO et al (2006) 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24:5313–5527PubMedCrossRef
8.
go back to reference Duffy MJ, van Dalen A, Haglund C et al (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43:1348–1360PubMedCrossRef Duffy MJ, van Dalen A, Haglund C et al (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43:1348–1360PubMedCrossRef
9.
go back to reference Chen CC, Yang SH, Lin JK et al (2005) Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res 124:169–174PubMedCrossRef Chen CC, Yang SH, Lin JK et al (2005) Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res 124:169–174PubMedCrossRef
10.
go back to reference Takagawa R, Fujii S, Ohta M et al (2008) Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol 15:3433–3439PubMedCrossRef Takagawa R, Fujii S, Ohta M et al (2008) Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol 15:3433–3439PubMedCrossRef
11.
go back to reference Secco GB, Fardelli R, Gianquinto D et al (2002) Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 28:418–423PubMedCrossRef Secco GB, Fardelli R, Gianquinto D et al (2002) Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 28:418–423PubMedCrossRef
12.
go back to reference Huh JW, Oh BR, Kim HR, Kim YJ (2010) Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer. J Surg Oncol 101:396–400PubMed Huh JW, Oh BR, Kim HR, Kim YJ (2010) Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer. J Surg Oncol 101:396–400PubMed
13.
go back to reference Oussoultzoglou E, Rosso E, Fuchshuber P, Stefanescu V, Diop B, Giraudo G, Pessaux P, Bachellier P, Jaeck D (2008) Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study. Arch Surg 143:1150–1158PubMedCrossRef Oussoultzoglou E, Rosso E, Fuchshuber P, Stefanescu V, Diop B, Giraudo G, Pessaux P, Bachellier P, Jaeck D (2008) Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study. Arch Surg 143:1150–1158PubMedCrossRef
14.
go back to reference Wang JY, Lu CY, Chu KS, Ma CJ, Wu DC, Tsai HL, Yu FJ, Hsieh JS (2007) Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res 39:245–250PubMedCrossRef Wang JY, Lu CY, Chu KS, Ma CJ, Wu DC, Tsai HL, Yu FJ, Hsieh JS (2007) Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res 39:245–250PubMedCrossRef
15.
go back to reference Choi JS, Min JS (1997) Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients. Yonsei Med J 38:1–7PubMed Choi JS, Min JS (1997) Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients. Yonsei Med J 38:1–7PubMed
16.
go back to reference Park YA, Lee KY, Kim NK et al (2006) Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 13:645–650PubMedCrossRef Park YA, Lee KY, Kim NK et al (2006) Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 13:645–650PubMedCrossRef
17.
go back to reference Wittekind C, Greene FL, Henson DE et al (eds) (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley, New York Wittekind C, Greene FL, Henson DE et al (eds) (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley, New York
18.
go back to reference Park IJ, Choi GS, Lim KH et al (2009) Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Ann Surg Oncol 16:3087–3093PubMedCrossRef Park IJ, Choi GS, Lim KH et al (2009) Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level. Ann Surg Oncol 16:3087–3093PubMedCrossRef
19.
go back to reference Kaiser AM, Kang JC, Chan LS et al (2006) The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer. Colorectal Dis 8:696–703PubMedCrossRef Kaiser AM, Kang JC, Chan LS et al (2006) The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer. Colorectal Dis 8:696–703PubMedCrossRef
20.
go back to reference Tsai HL, Chu KS, Huang YH et al (2009) Predictive factors of early relapse in UICC stage I–III colorectal cancer patients after curative resection. J Surg Oncol 100:736–743PubMedCrossRef Tsai HL, Chu KS, Huang YH et al (2009) Predictive factors of early relapse in UICC stage I–III colorectal cancer patients after curative resection. J Surg Oncol 100:736–743PubMedCrossRef
21.
go back to reference Kim JY, Kim NK, Sohn SK et al (2009) Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Ann Surg Oncol 16:2771–2778PubMedCrossRef Kim JY, Kim NK, Sohn SK et al (2009) Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels. Ann Surg Oncol 16:2771–2778PubMedCrossRef
22.
go back to reference Ogata Y, Murakami H, Sasatomi T et al (2009) Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. J Surg Oncol 99:65–70PubMedCrossRef Ogata Y, Murakami H, Sasatomi T et al (2009) Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. J Surg Oncol 99:65–70PubMedCrossRef
Metadata
Title
Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer
Authors
Jen-Kou Lin
Chun-Chi Lin
Shung-Haur Yang
Huann-Sheng Wang
Jeng-Kai Jiang
Yuan-Tzu Lan
Tzu-Chen Lin
Anna Fen-Yau Li
Wei-Shone Chen
Shih-Ching Chang
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
International Journal of Colorectal Disease / Issue 9/2011
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-011-1209-5

Other articles of this Issue 9/2011

International Journal of Colorectal Disease 9/2011 Go to the issue